EVIDENCE PROFILE / PUBLISHED
AOD-9604
AOD-9604 is a synthetic analogue based on a C-terminal region of human growth hormone, not full-length growth hormone. The reviewed source set did not provide a convincing peer-reviewed randomized human efficacy publication.
Evidence at a glance
- Human
- Not rated
- Animal/cell
- Not rated
- Approved medicine
- None foundScope: the sources reviewed.
Summarises how much research the profile's sources report, and of what kind. It is not a verdict on the compound or on any catalogue material.
PREPPY BOY ASKS
“A familiar name can hide a different molecule, fragment, formulation, or evidence story.”
The catalogue name is a starting point, not proof of formulation or identity. It has been studied for metabolic and lipolysis-related effects, primarily in animal models.
Identity
AOD-9604 is a synthetic analogue based on a C-terminal region of human growth hormone, not full-length growth hormone.
Biological mechanism or research interest
It has been studied for metabolic and lipolysis-related effects, primarily in animal models.
Verified approved human uses
No approved human use was verified in the reviewed sources; FDA's risk page says the nomination was withdrawn and identifies limited safety information.
Investigational human evidence
The reviewed source set did not provide a convincing peer-reviewed randomized human efficacy publication.
Popular claims versus demonstrated findings
Fat-loss claims often promote animal observations beyond what has been demonstrated in people.
Human versus animal or cell evidence
A 2000 study reported metabolic effects in obese Zucker rats; this is animal evidence.
Limitations and known risks
FDA notes potential immunogenicity and serious adverse-event reports with unclear causality; route-specific human safety remains inadequate.
